Updated on 7 October 2013
"We have made payments for renewal of our product registrations and the renewal process is on."
The statement added that it has maintained high levels of compliance owing to strict implementation of GMP, GLP, ICH guidelines. "We would also like to emphasize that until date our product has not been failed in quality aspects. We are committed to ensure public health and safety and have never and would not compromise on this," the statement further said.
It added, "We assure the Ghanaian public that we will take all necessary steps to assist the US FDA in its quest to protect public safety and to continue to provide the quality assured and affordable medicines in Ghana."